Astria Therapeutics (ATXS) Financials

$12.48

$-0.33 (-2.58%)

As on 16-Jan-2026 12:34EDT

Market cap

$718 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

5.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	0.71	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	0.71	--	--	--	--	--
Operating Expenses	137.22	111.56	83.03	53.50	194.98	37.44
Operating Profit (EBIT)	-136.51	-111.56	-83.03	-53.50	-194.98	-37.44
Other Income	--	--	--	1.67	--	--
Profit before Tax	-124.03	-94.26	-72.89	-51.83	-194.91	-37.30
Provision for Tax	0.04	--	0.02	-1.67	-164.74	-0.24
Profit after Tax (Net Income)	-124.03	-94.26	-72.89	-50.17	-194.91	-37.06
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-51.83	-219.35	-37.30

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	233.25	319.26	243.12	221.22	122.31	40.67
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	15.10	3.97	--	0.36	1.92	0.40
Current Liabilities	23.52	19.13	11.55	9.06	5.20	6.39
Total Liabilities	295.38	342.36	254.67	230.63	127.51	47.46

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	18.32	7.72	3.72	2.94	0.44	1.13
Current Assets	253.55	334.64	250.94	227.69	127.08	46.33
Total Assets	295.38	342.36	254.67	230.63	127.51	47.46
Total Debt*	4.46	5.35	0.33	0.94	0.37	1.05
Net Current Assets	230.03	315.51	239.39	218.63	121.87	39.94

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-81.21	-68.45	-43.53	-30.15	-32.49
Cash Flow from Investing Activities	--	-191.86	135.05	-167.13	-12.56	6.30
Cash from Financing Activities	--	157.20	88.40	144.72	104.28	40.86
Net Cash Inflow / Outflow	--	--	--	-65.94	--	--

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-2.15	-1.67	-2.00	-2.72	-15.19	-9.94
Cash EPS ($)	--	-1.67	-2.00	-2.72	-15.19	-9.94
Adjusted Book Value ($)	--	5.66	6.66	12.01	9.53	10.90
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.44	-1.87	-2.36	-2.35	-8.71
Free Cash Flow per Share ($)	--	-1.44	-1.87	-2.37	-2.35	-8.72

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-33.19	-31.31	-29.10	-237.13	-93.02
ROE (%)	-47.47	-33.52	-31.40	-29.21	-239.19	-97.04
ROA (%)	-36.87	-31.58	-30.04	-28.01	-222.79	-83.07
EBIT Margin (%)	-14,498.97	--	--	--	--	--
Net Margin (%)	-17,567.99	--	--	-3,005.69	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-1.38	-64.46	-26.78	-76.23	18.90	-38.20
Net Profit Growth (%)	-23.98	-29.32	-45.30	74.26	-425.88	-40.97
EPS Growth (%)	-2.24	0.16	0.27	0.82	-0.53	0.00
Book Value Growth (%)	-33.52	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-5.35	-3.85	-5.47	-0.35	-0.22
Price / Book Value	5.21	1.58	1.15	1.24	0.57	0.20
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-7.57	-1.63	-0.41	-0.94	1.84	0.96
Close Price ($)	7.28	8.94	7.68	14.89	5.39	12.84
High Price ($)	12.52	16.90	16.28	15.45	47.82	51.54
Low Price ($)	3.56	6.58	4.26	2.36	4.81	7.50
Market Cap ($ Cr)	718.13	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	0.02	0.00	0.00	0.00	0.03
Short term debt to equity ratio	0.01	0.00	0.00	0.00	0.00	0.02
Current Ratio	10.78	17.49	21.73	25.13	24.42	7.25
Quick Ratio	10.78	--	--	--	--	--
Interest Coverage	--	--	--	-32.06	-474.36	-158.62

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	2,442.35	--	--	--	--	--
Asset Turnover	0.00	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.